Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Merck Will Build Beijing R&D Center; Invest $1.5 Billion in China

publication date: Dec 6, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Merck announced plans to build an Asia Research & Development headquarters in Beijing, which will be devoted to innovative drug discovery and development. The new initiative is part of a broader $1.5 billion investment in China R&D that Merck will make over the next five years. Merck said the investment has two goals: building its own capabilities and fostering relationships with outside researchers. It expects the center to provide new drugs and vaccines that meet global needs. More details....

Stock Symbol: (NYSE: MRK)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners